Baj, J.; Bryliński, Ł.; Woliński, F.; Granat, M.; Kostelecka, K.; Duda, P.; Flieger, J.; Teresiński, G.; Buszewicz, G.; Furtak-Niczyporuk, M.;
et al. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know. Cancers 2022, 14, 1493.
https://doi.org/10.3390/cancers14061493
AMA Style
Baj J, Bryliński Ł, Woliński F, Granat M, Kostelecka K, Duda P, Flieger J, Teresiński G, Buszewicz G, Furtak-Niczyporuk M,
et al. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know. Cancers. 2022; 14(6):1493.
https://doi.org/10.3390/cancers14061493
Chicago/Turabian Style
Baj, Jacek, Łukasz Bryliński, Filip Woliński, Michał Granat, Katarzyna Kostelecka, Piotr Duda, Jolanta Flieger, Grzegorz Teresiński, Grzegorz Buszewicz, Marzena Furtak-Niczyporuk,
and et al. 2022. "Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know" Cancers 14, no. 6: 1493.
https://doi.org/10.3390/cancers14061493
APA Style
Baj, J., Bryliński, Ł., Woliński, F., Granat, M., Kostelecka, K., Duda, P., Flieger, J., Teresiński, G., Buszewicz, G., Furtak-Niczyporuk, M., & Portincasa, P.
(2022). Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know. Cancers, 14(6), 1493.
https://doi.org/10.3390/cancers14061493
